Medicine Description empaglimax 10mg
empaglimax 10mg tablets is a medication that contains empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor. This class of medications works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. By inhibiting SGLT2, empagliflozin reduces the threshold for glucose excretion, thereby lowering blood sugar levels in patients with type II diabetes. Furthermore, empagliflozin has been shown to confer cardiovascular benefits, particularly in patients with heart failure, through mechanisms that may involve reducing preload and afterload on the heart, improving renal function, and promoting natriuresis.
Indications and Uses of empaglimax 10mg tablets
- Management of type II diabetes mellitus
- Reduction of cardiovascular risk in patients with type II diabetes and established cardiovascular disease
- Adjunctive treatment in adults with heart failure who have type II diabetes
Side Effects of empaglimax 10mg tablets
- Urinary tract infections
- Genital mycotic infections
- Increased urination
- Hypoglycemia (when used with other antidiabetic agents)
- Dehydration and hypotension
- Kidney-related issues
Storage and Handling
Store empaglimax 10mg tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Patient Advice and Precautions
Patients should be regularly monitored for renal function and signs of dehydration. It is essential to maintain adequate hydration while using this medication. Patients should be advised to report any signs of urinary or genital infections promptly. It is also important to inform healthcare providers about any other medications being taken to avoid potential interactions.